BlackRock Fund Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BlackRock Fund Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$820K	Sell	157,987 -49,498	-24%	-$857K	﹤0.01%	3236
2016 Q3	$5.23M	Buy	207,485 +10,270	+5%	+$259K	﹤0.01%	2826
2016 Q2	$4.88M	Buy	197,215 +5,658	+3%	+$160K	﹤0.01%	2824
2016 Q1	$5.55M	Sell	191,557 -1,233	-0.6%	-$33.5K	﹤0.01%	2687
2015 Q4	$7.16M	Buy	192,790 +64,409	+50%	+$2.84M	﹤0.01%	2641
2015 Q3	$6.25M	Buy	128,381 +11,258	+10%	+$787K	﹤0.01%	2668
2015 Q2	$8.08M	Buy	117,123 +109,828	+1,506%	+$5.08M	﹤0.01%	2631
2015 Q1	$261K	Buy	7,295 +3,242	+80%	+$96K	﹤0.01%	3415
2014 Q4	$51K	Buy	4,053 +2,515	+164%	+$36.5K	﹤0.01%	3672
2014 Q3	$24K	Buy	+1,538	New	+$32.4K	﹤0.01%	3758

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Fund Advisors's ANTH Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Anthera Pharmaceuticals, Inc. (ANTH) stake by 24% in Q4 2016, selling an estimated $857K and leaving 157,987 shares worth $820K. The position accounts for ﹤0.01% of the portfolio, ranked #3236.

BlackRock Fund Advisors first reported a position in ANTH in Q3 2014 and has held it in 10 quarters since. The position peaked at $8.08M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

BlackRock Fund Advisors held 157,987 shares of Anthera Pharmaceuticals, Inc. worth $820K as of Q4 2016.
BlackRock Fund Advisors sold 49,498 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $857K.
Anthera Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3236 holding.
BlackRock Fund Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Anthera Pharmaceuticals, Inc. position peaked at $8.08M in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.